Fred Poordad

  • 15401 Citations
  • 55 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Fred Poordad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients with Type-2 Diabetes with Biopsy-proven Nonalcoholic Fatty Liver Disease

Singh, A., Gosai, F., Siddiqui, M. T., Gupta, M., Lopez, R., Lawitz, E., Poordad, F., Carey, W., McCullough, A. & Alkhouri, N., Jan 1 2020, (Accepted/In press) In : Journal of Clinical Gastroenterology.

Research output: Contribution to journalArticle

  • 2 Scopus citations

    Avatrombopag, an alternate treatment option to reduce platelet transfusions in patients with thrombocytopenia and chronic liver disease-integrated analyses of 2 phase 3 studies

    Poordad, F., Terrault, N. A., Alkhouri, N., Tian, W., Allen, L. F. & Rabinovitz, M., 2020, In : International Journal of Hepatology. 2020, 5421632.

    Research output: Contribution to journalArticle

    Open Access
  • Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies

    Yao, B. B., Fredrick, L. M., Schnell, G., Kowdley, K. V., Kwo, P. Y., Poordad, F., Nguyen, K., Lee, S. S., George, C., Wong, F., Gane, E., Abergel, A., Spearman, C. W., Nguyen, T., Hung Le, M., Pham, T. T. T., Mensa, F. & Asselah, T., 2020, (Accepted/In press) In : Liver International.

    Research output: Contribution to journalArticle

    Open Access
  • Long-term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials

    Poordad, F., Castro, R. S. E., Asatryan, A., Aguilar, H., Cacoub, P., Dieterich, D., Marinho, R. T., Carvalho, A., Siddique, A., Hu, Y. B., Charafeddine, M., Bondin, M., Khan, N., Cohen, D. E. & Felizarta, F., May 1 2020, In : Journal of Viral Hepatitis. 27, 5, p. 497-504 8 p.

    Research output: Contribution to journalArticle

  • Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients: Long-term follow-up results from the open-label, Phase II IMPACT study

    Lawitz, E., Poordad, F., Gutierrez, J. A., Beumont, M., Beets, G., Vandevoorde, A., Remoortere, P. V., Luo, D., Vijgen, L., Eygen, V. V. & Gamil, M., Jun 1 2020, In : Health Science Reports. 3, 2, e145.

    Research output: Contribution to journalArticle

    Open Access
  • Press / Media

    Long-term Safety and Efficacy of OBV/PTV/r + DSV in HCV

    Fred Poordad


    2 items of Media coverage

    Press/Media: Press / Media